The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This stock page is the Follow view. The Build view lets your agent query SNSE owners, fund changes, insider filings, and source links through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/SNSE"
Use Arkolith to show who owns SNSE, which funds added or reduced it, and which SEC filings prove each claim.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Cormorant Asset Management, LP | $9.7M | 306K | ▲New +306K sh | Q1 2026 | |
| 2 | SUVRETTA CAPITAL MANAGEMENT, LLC | $1.1M | 35K | ▲New +35K sh | Q1 2026 | |
| 3 | Logos Global Management LP | $946K | 30K | ▲New +30K sh | Q1 2026 | |
| 4 | BOOTHBAY FUND MANAGEMENT, LLC | $823K | 26K | ▲New +26K sh | Q1 2026 | |
| 5 | VANGUARD FIDUCIARY TRUST CO | $199K | 6K | ▲New +6K sh | Q1 2026 | |
| 6 | SBI Securities Co., Ltd. | $126 | 4 | —Held | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jun 10, 2026 | Holmen Bob | Director | Grant (A) | 13K | $0 |
| Jun 10, 2026 | Gerry Christopher | President & PEO | Grant (A) | 220K | $0 |
| Jun 10, 2026 | Donenberg Phillip B. | Director | Grant (A) | 13K | $0 |
| Feb 13, 2026 | Donenberg Phillip B. | Director | Grant (A) | 2K | $0 |
| Dec 9, 2025 | Cambrian BioPharma Inc | 10% Owner | Sell (S) | 395 | $3K |
| Dec 9, 2025 | Peyer James | 10% Owner | Sell (S) | 395 | $3K |
| Dec 9, 2025 | Peyer James | 10% Owner | Sell (S) | 3K | $21K |
| Dec 9, 2025 | Peyer James | 10% Owner | Sell (S) | 446 | $4K |
| Dec 9, 2025 | Peyer James | 10% Owner | Option exercise (M) | 395 | $3K |
| Dec 9, 2025 | Peyer James | 10% Owner | Option exercise (M) | 395 | $0 |
| Dec 9, 2025 | Cambrian BioPharma Inc | 10% Owner | Sell (S) | 3K | $27K |
| Dec 9, 2025 | Cambrian BioPharma Inc | 10% Owner | Sell (S) | 446 | $4K |
| Company | Co-held by | Combined value |
|---|---|---|
| ERASCA INCERAS | 5 funds | $329.8M |
| TANGO THERAPEUTICS INCTNGX | 5 funds | $104.5M |
| BIOGEN INCBIIB | 5 funds | $39.7M |
| NVIDIA CORPNVDA | 4 funds | $718.1M |
| PRAXIS PRECISION MEDICINES IPRAX | 4 funds | $382.8M |
| AMAZON.COM INCAMZN | 4 funds | $296.3M |
| MICROSOFT CORPMSFT | 4 funds | $258.4M |
| TAIWAN SEMICONDUCTOR-SP ADRTSM | 4 funds | $197.3M |
| META PLATFORMS INC-CLASS AMETA | 4 funds | $176.2M |
| CENTESSA PHARMACEUTICALS-ADRCNTA | 4 funds | $127.7M |
| GENERAL ELECTRICGE | 4 funds | $121.6M |
| TERNS PHARMACEUTICALS INC430 | 4 funds | $120.5M |
Ranked by how many of SNSE's institutional holders also hold each name, a cross-fund conviction signal. Via the MCP server (ticker.co_held).
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for SNSE. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes. Every panel above is one call to the Arkolith API & MCP server.